Jassem J - Search Results

1

Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.

Cufer T, Ciuleanu TE, Berzinec P, Galffy G, Jakopovic M, Jassem J, Jovanovic D, Mihaylova Z, Ostoros G, Thallinger C, Zemanova M, Zielinski C. Cufer T, et al. Among authors: jassem j. Oncologist. 2020 Mar;25(3):e598-e601. doi: 10.1634/theoncologist.2019-0523. Epub 2019 Nov 29. Oncologist. 2020. PMID: 32162818 Free PMC article.

2

Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG).

Eckhardt S, Kolaric K, Vukas D, Kánitz E, Schoket Z, Jassem J, Vuletic L, Jelic S, Mechl Z, Koza I, et al. Eckhardt S, et al. Among authors: jassem j. Med Oncol Tumor Pharmacother. 1990;7(1):19-23. Med Oncol Tumor Pharmacother. 1990. PMID: 2160033 Clinical Trial.

3

Autopsy findings in small cell lung cancer.

Jereczek B, Jassem J, Karnicka-Młodkowska H, Badzio A, Mos-Antkowiak R, Szczepek B, Chojak E, Dziadziuszko R, Lisowska B, Malak K. Jereczek B, et al. Among authors: jassem j. Neoplasma. 1996;43(2):133-7. Neoplasma. 1996. PMID: 8843976

4

Chemotherapy of advanced non-small cell lung cancer.

Jassem J. Jassem J. Ann Oncol. 1999;10 Suppl 6:77-82. Ann Oncol. 1999. PMID: 10676557 Review.

5

Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer.

Dworakowska D, Gózdz S, Jassem E, Badzio A, Kobierska G, Urbaniak A, Skokowski J, Damps I, Jassem J. Dworakowska D, et al. Among authors: jassem j, jassem e. Lung Cancer. 2002 Jan;35(1):35-41. doi: 10.1016/s0169-5002(01)00287-2. Lung Cancer. 2002. PMID: 11750711 Review.

6

Combined chemotherapy and radiation in locally advanced non-small-cell lung cancer.

Jassem J. Jassem J. Lancet Oncol. 2001 Jun;2(6):335-42. doi: 10.1016/S1470-2045(00)00387-9. Lancet Oncol. 2001. PMID: 11905749 Review.

7

Role of chemotherapy in the multimodality approach of non-small cell lung cancer.

Jassem J. Jassem J. Curr Probl Cancer. 2003 Jan-Feb;27(1):64-8. doi: 10.1067/mcn.2003.11. Curr Probl Cancer. 2003. PMID: 12569354 Review. No abstract available.

8

Chemoradiotherapy of non-small cell lung cancer.

Jassem J. Jassem J. Expert Rev Anticancer Ther. 2002 Aug;2(4):402-7. doi: 10.1586/14737140.2.4.402. Expert Rev Anticancer Ther. 2002. PMID: 12647983 Review.

9

Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.

Chmara M, Wozniak A, Ochman K, Kobierska G, Dziadziuszko R, Sosinska-Mielcarek K, Jassem E, Skokowski J, Jassem J, Limon J. Chmara M, et al. Among authors: jassem j, jassem e. Anticancer Res. 2004 Nov-Dec;24(6):4259-63. Anticancer Res. 2004. PMID: 15736482 Free article.

10

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N, Ciuleanu T, Cucevic B, Gyurkovits K, Ulsperger E, Jassem J, Grgic M, Saip P, Szilasi M, Wiltschke C, Wagnerova M, Oskina N, Soldatenkova V, Zielinski C, Wenczl M; Central European Cooperative Oncology Group CECOG. Brodowicz T, et al. Among authors: jassem j. Lung Cancer. 2006 May;52(2):155-63. doi: 10.1016/j.lungcan.2006.01.006. Epub 2006 Mar 29. Lung Cancer. 2006. PMID: 16569462 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters